vs
Apellis Pharmaceuticals, Inc.（APLS）与APPIAN CORP（APPN）财务数据对比。点击上方公司名可切换其他公司
APPIAN CORP的季度营收约是Apellis Pharmaceuticals, Inc.的1.0倍（$202.9M vs $199.9M），APPIAN CORP净利率更高（-2.5% vs -29.5%，领先27.0%），APPIAN CORP同比增速更快（21.7% vs -5.9%），APPIAN CORP自由现金流更多（$270.0K vs $-14.3M），过去两年APPIAN CORP的营收复合增速更高（16.4% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Appian是总部位于美国弗吉尼亚州麦克莱恩的云计算与企业软件厂商，身处杜勒斯科技走廊产业带。公司提供平台即服务（PaaS）产品，支持企业级软件开发，业务覆盖北美、欧洲、中东及东南亚市场，深耕低代码开发、流程挖掘、业务流程管理和案例管理领域。
APLS vs APPN — 直观对比
营收规模更大
APPN
是对方的1.0倍
$199.9M
营收增速更快
APPN
高出27.6%
-5.9%
净利率更高
APPN
高出27.0%
-29.5%
自由现金流更多
APPN
多$14.6M
$-14.3M
两年增速更快
APPN
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $202.9M |
| 净利润 | $-59.0M | $-5.1M |
| 毛利率 | — | 64.8% |
| 营业利润率 | -25.6% | -0.3% |
| 净利率 | -29.5% | -2.5% |
| 营收同比 | -5.9% | 21.7% |
| 净利润同比 | -62.2% | 62.6% |
| 每股收益（稀释后） | $-0.40 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSAPPN
| Q4 25 | $199.9M | $202.9M | ||
| Q3 25 | $458.6M | $187.0M | ||
| Q2 25 | $178.5M | $170.6M | ||
| Q1 25 | $166.8M | $166.4M | ||
| Q4 24 | $212.5M | $166.7M | ||
| Q3 24 | $196.8M | $154.1M | ||
| Q2 24 | $199.7M | $146.4M | ||
| Q1 24 | $172.3M | $149.8M |
净利润APLSAPPN
| Q4 25 | $-59.0M | $-5.1M | ||
| Q3 25 | $215.7M | $7.8M | ||
| Q2 25 | $-42.2M | $-312.0K | ||
| Q1 25 | $-92.2M | $-1.2M | ||
| Q4 24 | $-36.4M | $-13.6M | ||
| Q3 24 | $-57.4M | $-2.1M | ||
| Q2 24 | $-37.7M | $-43.6M | ||
| Q1 24 | $-66.4M | $-32.9M |
毛利率APLSAPPN
| Q4 25 | — | 64.8% | ||
| Q3 25 | — | 75.8% | ||
| Q2 25 | — | 74.3% | ||
| Q1 25 | — | 76.6% | ||
| Q4 24 | — | 67.8% | ||
| Q3 24 | — | 75.9% | ||
| Q2 24 | — | 73.1% | ||
| Q1 24 | — | 74.6% |
营业利润率APLSAPPN
| Q4 25 | -25.6% | -0.3% | ||
| Q3 25 | 48.7% | 7.0% | ||
| Q2 25 | -18.6% | -6.4% | ||
| Q1 25 | -50.0% | -0.5% | ||
| Q4 24 | -12.3% | 3.0% | ||
| Q3 24 | -24.0% | -4.6% | ||
| Q2 24 | -14.7% | -26.8% | ||
| Q1 24 | -36.0% | -13.0% |
净利率APLSAPPN
| Q4 25 | -29.5% | -2.5% | ||
| Q3 25 | 47.0% | 4.2% | ||
| Q2 25 | -23.6% | -0.2% | ||
| Q1 25 | -55.3% | -0.7% | ||
| Q4 24 | -17.1% | -8.2% | ||
| Q3 24 | -29.2% | -1.4% | ||
| Q2 24 | -18.9% | -29.8% | ||
| Q1 24 | -38.5% | -22.0% |
每股收益（稀释后）APLSAPPN
| Q4 25 | $-0.40 | $-0.06 | ||
| Q3 25 | $1.67 | $0.10 | ||
| Q2 25 | $-0.33 | $0.00 | ||
| Q1 25 | $-0.74 | $-0.02 | ||
| Q4 24 | $-0.30 | $-0.18 | ||
| Q3 24 | $-0.46 | $-0.03 | ||
| Q2 24 | $-0.30 | $-0.60 | ||
| Q1 24 | $-0.54 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $187.2M |
| 总债务越低越好 | — | $240.8M |
| 股东权益账面价值 | $370.1M | $-47.0M |
| 总资产 | $1.1B | $691.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSAPPN
| Q4 25 | $466.2M | $187.2M | ||
| Q3 25 | $479.2M | $191.6M | ||
| Q2 25 | $370.0M | $184.8M | ||
| Q1 25 | $358.4M | $199.7M | ||
| Q4 24 | $411.3M | $159.9M | ||
| Q3 24 | $396.9M | $99.2M | ||
| Q2 24 | $360.1M | $120.8M | ||
| Q1 24 | $325.9M | $170.1M |
总债务APLSAPPN
| Q4 25 | — | $240.8M | ||
| Q3 25 | — | $245.7M | ||
| Q2 25 | — | $245.6M | ||
| Q1 25 | — | $248.0M | ||
| Q4 24 | — | $250.4M | ||
| Q3 24 | — | $252.8M | ||
| Q2 24 | — | $254.0M | ||
| Q1 24 | $93.1M | $255.1M |
股东权益APLSAPPN
| Q4 25 | $370.1M | $-47.0M | ||
| Q3 25 | $401.2M | $-48.5M | ||
| Q2 25 | $156.3M | $-53.7M | ||
| Q1 25 | $164.2M | $-31.7M | ||
| Q4 24 | $228.5M | $-32.6M | ||
| Q3 24 | $237.1M | $-49.8M | ||
| Q2 24 | $264.3M | $-45.7M | ||
| Q1 24 | $266.7M | $-9.7M |
总资产APLSAPPN
| Q4 25 | $1.1B | $691.4M | ||
| Q3 25 | $1.1B | $611.7M | ||
| Q2 25 | $821.4M | $590.7M | ||
| Q1 25 | $807.3M | $592.9M | ||
| Q4 24 | $885.1M | $621.0M | ||
| Q3 24 | $901.9M | $549.9M | ||
| Q2 24 | $904.5M | $554.6M | ||
| Q1 24 | $831.9M | $595.4M |
负债/权益比APLSAPPN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $1.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $270.0K |
| 自由现金流率自由现金流/营收 | -7.1% | 0.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $59.6M |
8季度趋势，按日历期对齐
经营现金流APLSAPPN
| Q4 25 | $-14.2M | $1.1M | ||
| Q3 25 | $108.5M | $18.7M | ||
| Q2 25 | $4.4M | $-1.9M | ||
| Q1 25 | $-53.4M | $45.0M | ||
| Q4 24 | $19.4M | $13.9M | ||
| Q3 24 | $34.1M | $-8.2M | ||
| Q2 24 | $-8.3M | $-17.6M | ||
| Q1 24 | $-133.0M | $18.9M |
自由现金流APLSAPPN
| Q4 25 | $-14.3M | $270.0K | ||
| Q3 25 | $108.3M | $18.1M | ||
| Q2 25 | $4.4M | $-3.1M | ||
| Q1 25 | $-53.4M | $44.3M | ||
| Q4 24 | $19.3M | $13.4M | ||
| Q3 24 | — | $-8.6M | ||
| Q2 24 | $-8.4M | $-18.3M | ||
| Q1 24 | $-133.3M | $16.7M |
自由现金流率APLSAPPN
| Q4 25 | -7.1% | 0.1% | ||
| Q3 25 | 23.6% | 9.7% | ||
| Q2 25 | 2.5% | -1.8% | ||
| Q1 25 | -32.0% | 26.6% | ||
| Q4 24 | 9.1% | 8.0% | ||
| Q3 24 | — | -5.6% | ||
| Q2 24 | -4.2% | -12.5% | ||
| Q1 24 | -77.3% | 11.1% |
资本支出强度APLSAPPN
| Q4 25 | 0.1% | 0.4% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.4% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.2% | 1.5% |
现金转化率APLSAPPN
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 2.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
APPN
| Subscriptions Software And Support | $162.3M | 80% |
| Professional Services | $40.6M | 20% |
